Metabolic reprogramming has emerged as a novel strategy in the fight against cancer. Tumors often exhibit altered metabolic pathways to support their rapid growth and survival. By targeting these aberrant metabolic processes, researchers aim to disrupt tumor progression and enhance therapeutic effic